Continuing Education Courses
Continuing Education for MLS & MLT
Continuing Education for Phlebotomists
Continuing Education for Histologists
HR Courses
Intro to the Medical Lab
Video Continuing Education Courses
All Available Courses
Exam Simulators
Exam Simulator for MLS & MLT
NSH + LabCE Histology Exam Simulator
Phlebotomy Exam Simulator
Molecular Exam Simulator
Case Simulators
Bacteriology Case Simulator
Blood Bank Case Simulator
Blood Culture Gram Stain Case Simulator
Body Fluid Case Simulator
RBC Morphology Simulator
Urinalysis Case Simulator
White Blood Cell Differential Case Simulator
Advanced WBC Differential Case Simulator
LabCE Quiz Game
Contact & Support
Log In
Log In
Direct Factor Xa Inhibitors
How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 184 CE courses, most popular
$109
Add to cart
Pick Your Courses
Up to 8 CE hours
$55
Add to cart
Individual course
$25
Add to cart
The page below is a sample from the LabCE course
Antiplatelet and Anticoagulant Pharmacology for the Laboratory Professional
. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.
Learn more about Antiplatelet and Anticoagulant Pharmacology for the Laboratory Professional (online CE course)
Direct Factor Xa Inhibitors
Examples:
This class of drugs includes
rivaroxaban
and
apixaban
. These drugs are administered orally.
Mechanism of action:
These drugs bind to factor Xa, resulting in the direct inhibition of Xa. Once factor Xa is inhibited, it cannot function in the coagulation cascade and the fibrin clot cannot form.
Use:
Direct Factor Xa Inhibitors are used in the chronic management of hypercoagulability.
Laboratory measurement:
These drugs do not require routine laboratory monitoring.
Toxicity:
All anticoagulants can cause excessive bleeding, but there is no reversal agent for this class of medications. However, Prothrombin Complex Concentrate (PCC) does provide a partial reversal of these drugs.
For more in-depth knowledge on how these medications affect coagulation testing:
http://emj.bmj.com/content/emermed/early/2015/05/17/emermed-2015-204891.full.pdf
X
×